|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,060.00 TWD | +4.95% |
|
+11.70% | +125.53% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
| Market Cap | 394B 12.45B 10.85B 10.05B 9.41B 17.64B 1,174B 17.75B 119B 46.21B 578B 46.72B 45.71B 2,007B | P/E 2026 * |
41.2x | P/E 2027 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 371B 11.72B 10.22B 9.46B 8.86B 16.61B 1,106B 16.71B 112B 43.5B 544B 43.98B 43.04B 1,890B | EV / Sales 2026 * |
15.9x | EV / Sales 2027 * | 10x |
| Free-Float |
77.66% | Yield 2026 * |
-
| Yield 2027 * | 0.14% |
| 1 day | +4.95% | ||
| 1 week | +11.70% | ||
| Current month | +13.98% | ||
| 1 month | +33.17% | ||
| 3 months | +64.09% | ||
| 6 months | +114.36% | ||
| Current year | +125.53% |
| 1 week | 948 |  | 1,075 |
| 1 month | 784 | | 1,075 |
| Current year | 470 | | 1,075 |
| 1 year | 438.85 | | 1,075 |
| 3 years | 246.91 | | 1,075 |
| 5 years | 62.18 | | 1,075 |
| 10 years | 48.3 | | 1,075 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 31/12/2002 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 13/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 31/08/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 29/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| +1.18% | +5.20% | +78.89% | +107.20% | 11.66B | |
| Average | +1.39% | +2.67% | +40.90% | +109.01% | 22.59B | |
| Weighted average by Cap. | +1.60% | +1.74% | +42.88% | +100.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 23.27B 735M 641M 594M 556M 1.04B 69.37B 1.05B 7.04B 2.73B 34.15B 2.76B 2.7B 119B | 36.91B 1.17B 1.02B 942M 882M 1.65B 110B 1.66B 11.17B 4.33B 54.16B 4.38B 4.28B 188B |
| Net income | 9.82B 310M 270M 250M 234M 440M 29.26B 442M 2.97B 1.15B 14.4B 1.16B 1.14B 50.01B | 14.05B 444M 387M 358M 336M 629M 41.89B 633M 4.25B 1.65B 20.62B 1.67B 1.63B 71.59B |
| Net Debt | -23.05B -728M -635M -588M -550M -1.03B -68.71B -1.04B -6.98B -2.7B -33.82B -2.73B -2.67B -117B | -24.86B -785M -685M -634M -594M -1.11B -74.12B -1.12B -7.52B -2.92B -36.48B -2.95B -2.89B -127B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 1,060.00 NT$ | +4.95% | 2,842,156 |
| 17/06/26 | 1,010.00 NT$ | +1.92% | 2,486,382 |
| 16/06/26 | 991.00 NT$ | +4.10% | 1,998,856 |
| 15/06/26 | 952.00 NT$ | +0.32% | 1,805,808 |
| 12/06/26 | 949.00 NT$ | +1.61% | 1,923,493 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
